Poland - Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale

Since 2014, Poland Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale decreased by 1.1% year on year. With €142,757,293.7 in 2019, the country was ranked number 3 comparing other countries in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale. Poland is overtaken by United Kingdom, which was ranked number 2 at €195,933,082.68 and is followed by Hungary at €128,523,052.44. Germany topped the ranking with €2,350,575,277.14 in 2019, -3.4% versus 2018. Estonia recorded the best 5 years average growth at +11.1% per year, while Netherlands witnessed the worst performance at -38.7% per year.

Loading...

Date Euros
2019 142,757,293.70
2018 126,345,864.00
2017 145,531,665.00
2016 191,176,705.00
2015 180,721,326.00
Download all data from 2002 to 2019

How does Poland rank in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale?

# 17 Countries Euros Last YoY 5‑years CAGR
1 #1
Germany
2,350,575,277.14 2019 -3.4 % +8.0 % View data
2 #2
United Kingdom
195,933,082.68 2019 +2.5 % -5.9 % View data
3 #3
Poland
142,757,293.70 2019 +13.0 % -1.1 % View data
4 #4
Hungary
128,523,052.44 2019 +6.3 % -2.7 % View data
5 #5
France
102,455,978.25 2019 -18.9 % -0.0 % View data
Compare all 17 countries

Go Top